In other countries
The same active substances on other registers, the same brand first.
- Act PramipexoleCanada · 1.5 MG · Tablet · Teva Canada LimitedSame form
- Act PramipexoleCanada · 0.5 MG · Tablet · Teva Canada LimitedSame form
- Act PramipexoleCanada · 1 MG · Tablet · Teva Canada LimitedSame form
- MIRAPEXIN 0,18 mg COMPRIMIDOSSpain · 0,18 mg · comprimido · Boehringer Ingelheim International GmbhSame form
- MIRAPEXIN 0,18 mg COMPRIMIDOSSpain · 0,18 mg · comprimido · Boehringer Ingelheim International GmbhSame form
- MIRAPEXIN 0,26 mg COMPRIMIDOS DE LIBERACION PROLONGADASpain · 0,26 mg · comprimido de liberación prolongada · Boehringer Ingelheim International GmbhSame form
- Pramipeksol Pliva 0,26 mg tablete s produljenim oslobađanjemCroatia · tableta s produljenim oslobađanjem · Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, HrvatskaSame form
- Pramipeksol Pliva 0,52 mg tablete s produljenim oslobađanjemCroatia · tableta s produljenim oslobađanjem · Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, HrvatskaSame form
- Pramipeksol Pliva 1,05 mg tablete s produljenim oslobađanjemCroatia · tableta s produljenim oslobađanjem · Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, HrvatskaSame form
- Glepark 0,088 mg tablettenNetherlands · Tablet · Glenmark Arzneimittel GmbHSame form
- Glepark 0,18 mg tablettenNetherlands · Tablet · Glenmark Arzneimittel GmbHSame form
- Glepark 0,35 mg tablettenNetherlands · Tablet · Glenmark Arzneimittel GmbHSame form
- RamipexNew Zealand · Tab 1 mgSame form
- RamipexNew Zealand · Tab 0.25 mgSame form
- Mirapexin®Serbia · 2.1mg · tableta sa produženim oslobađanjem · Boehringer Ingelheim Serbia D.O.O. BeogradSame form
- Mirapexin®Serbia · 1.05mg · tableta sa produženim oslobađanjem · Boehringer Ingelheim Serbia D.O.O. BeogradSame form
- Mirapexin®Serbia · 0.26mg · tableta sa produženim oslobađanjem · Boehringer Ingelheim Serbia D.O.O. BeogradSame form
- Sifrol 0.088 MG (Equ.0.125MG) TabSaudi Arabia · Boehringer IngelheimSame form
- Sifrol 0.18 MG (Equ.0.25MG) TabSaudi Arabia · Boehringer IngelheimSame form
- Sifrol 0.7MG (Equ. 1.00MG) TabSaudi Arabia · Boehringer IngelheimSame form
- Sifrol Extended Release Tablet 0.375 mgSingapore · 0.375mg · tablet, extended release · Boehringer Ingelheim Singapore Pte. LTD.Same form
- Sifrol Extended Release Tablet 1.5mgSingapore · 1.500mg · tablet, extended release · Boehringer Ingelheim Singapore Pte. LTD.Same form
- SIFROL TABLET 0.125 mgSingapore · 0.125mg · tablet · Boehringer Ingelheim Singapore Pte. LTD.Same form
- Pramipexole DihydrochlorideUnited States · 0.375MG, 0.75MG, 1.5MG … · tablet, extended release · Actavis ElizabethSame form
- Pramipexole DihydrochlorideUnited States · 0.125MG, 0.25MG, 0.5MG … · tablet · AlembicSame form
- Mirapex ERUnited States · 0.375MG, 0.75MG, 1.5MG … · tablet, extended release · Boehringer IngelheimSame form
- dicloridrato de pramipexolBrazil · Ranbaxy Farmacêutica LtdaSame substance
- Dicloridrato de PramipexolBrazil · Aché Laboratórios Farmacêuticos S.ASame substance
- dicloridrato de pramipexolBrazil · Fundação Oswaldo CruzSame substance
- MirapexinEuropean Union · Boehringer Ingelheim International GmbHSame substance
- OprymeaEuropean Union · Krka, d.d., Novo mestoSame substance
- Pramipexole TevaEuropean Union · Teva Pharma B.V.Same substance
- CALMOLAN 0,26 mgRomania · 0,26mg · compr. elib. prel. · G.L. Pharma GMBHSame substance
- CALMOLAN 0,52 mgRomania · 0,52mg · compr. elib. prel. · G.L. Pharma GMBHSame substance
- CALMOLAN 2,1 mgRomania · 2,1mg · compr. elib. prel. · G.L. Pharma GMBHSame substance
- Mixole prolonged-release tablets 0.375 mgTaiwan · 持續性藥效錠 · 美時化學製藥股份有限公司Same substance
- Mixole prolonged-release tablets 0.75 mgTaiwan · 持續性藥效錠 · 美時化學製藥股份有限公司Same substance
- Mixole prolonged-release tablets 1.5mgTaiwan · 持續性藥效錠 · 美時化學製藥股份有限公司Same substance
Packs
| Pack | Code | Status |
|---|---|---|
| 0,26 MG COMPRESSE A RILASCIO PROLUNGATO- 10 COMPRESSE IN BLISTER OPA/AL/DESICCANT/PE-AL | 049577012 | Autorizzata |
| 0,52 MG COMPRESSE A RILASCIO PROLUNGATO- 10 COMPRESSE IN BLISTER OPA/AL/DESICCANT/PE-AL | 049577024 | Autorizzata |
| 0,52 MG COMPRESSE A RILASCIO PROLUNGATO- 30 COMPRESSE IN BLISTER OPA/AL/DESICCANT/PE-AL | 049577036 | Autorizzata |
| 1,05 MG COMPRESSE A RILASCIO PROLUNGATO- 30 COMPRESSE IN BLISTER OPA/AL/DESICCANT/PE-AL | 049577048 | Autorizzata |
| 2,1 MG COMPRESSE A RILASCIO PROLUNGATO- 30 COMPRESSE IN BLISTER OPA/AL/DESICCANT/PE-AL | 049577051 | Autorizzata |
| 3,15 MG COMPRESSE A RILASCIO PROLUNGATO- 30 COMPRESSE IN BLISTER OPA/AL/DESICCANT/PE-AL | 049577063 | Autorizzata |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Agenzia Italiana del Farmaco (AIFA), Italy
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Pramipexole
- Dosage form
- Compressa a rilascio prolungato
- Register
- Italy (AIFA)
- Status
- Authorised
- Status in the register
- Autorizzata
- Registration
- AIC 049577
- Marketing authorisation holder
- Doc Generici SRL
- ATC code
- N04BC05
- Group
- Nervous system
- Procedure
- Procedura Mutuo riconoscimento o Decentrata
- Supply
- Medicinali soggetti a prescrizione medica